Verastem, Inc.
Methods and compositions for treating abnormal cell growth
Last updated:
Abstract:
The present invention relates to, inter alia, combinations, methods, compositions, and oral dosage forms of a FAK inhibitor and a MEK inhibitor, for treating abnormal cell growth (e.g., cancer).
Status:
Grant
Type:
Utility
Filling date:
2 Apr 2018
Issue date:
10 Sep 2019